ArticleAbdominal radiology (New York)2026
Transformer-based ultrasound radiomics for novel multi-task automated segmentation and classification of ovarian tumors.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and evaluate a comprehensive AI-driven pipeline for automated segmentation and multi-class classification of ovarian tumors in ultrasound images using advanced transformer-based models and radiomic analysis. MATERIALS AND
methodsThe study was a multi-center, retrospective study that included ultrasound data of 1,907 patients in 4 clinical centers, with 1,364 patients being used as a model training and validation and 543 as an external test. Five transformer-based segmentation models were used to outline tumour regions namely SegFormer, Swin-UNet, DPT, nnU-Net and HRFormer. Dice Similarity Coefficient (DSC), Hausdorff Distance (HD) and Relative Absolute Volume Difference (RAVD) were used to measure segmentation accuracy. Radiomic features (n = 215) were taken out through SERA platform, following the IBSI instructions. Mutual Information (MI), LASSO and Recursive Feature Elimination (RFE) were used as feature selection methods. Five models were considered to classify them: TabTransformer, TabNet, MLP, XGBoost, and KAN. Three clinically significant classification tasks, including tumour type, histological subtype, and FIGO staging, were covered. The models were checked by five-fold cross-validation and externally tested. SHAP analysis delivered interpretability.
resultsSegFormer was found to be the most accurate in terms of segmentation (mean DSC > 91%), which is higher than other U-Net-based models in earlier research. To classify, the TabTransformer selected by MI had the highest test accuracies in all tasks: tumour type (92.7 per cent.), histological subtype (92.1 per cent.), and FIGO stage (92.0 per cent). The accuracy of the external tests was over 90 per cent in all the tasks. SHAP analysis demonstrated the important radiomic features that make classification decisions, which is clinically transparent. There was no difference in performance between centers and imaging conditions.
conclusionsThe suggested pipeline proves to be very accurate, general and interpretable in automated ovarian cancer diagnostics based on ultrasound imaging. It provides a powerful framework of clinical implementation and future application with multimodal data to support decisions better.
Indexed as
Identifiers
41251739What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.